MedTrace Logo

Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance

NCT04459520 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1400

Last updated 2020-08-20

No results posted yet for this study

Summary

The purpose of this research is to conduct a cross-sectional survey to investigate how people's lifestyle decisions and social distancing choices are affected by the medical information they receive. The hypothesis is that a positive COVID-19 test result will lead to study participants having the greatest self-isolation intentions compared to those who are only clinically diagnosed for COVID-19 without a confirmatory diagnostic test result or those who receive a negative COVID-19 test result.

Conditions

Interventions

BEHAVIORAL

Positive COVID Test Result - Hypothetical Scenario

Participants will be asked to imagine that they have tested positive (PCR) for an active COVID-19 infection and that their physician has clinically diagnosed them with COVID-19.

BEHAVIORAL

Negative COVID Test Result - Hypothetical Scenario

Participants will be asked to imagine that they have tested negative (PCR) for an active COVID-19 infection.

BEHAVIORAL

Unavailable COVID Test Result - Hypothetical Scenario

Participants will be asked to imagine that testing is not available for active COVID-19 infections but that their physician has clinically diagnosed them with COVID-19.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-23
Primary Completion
2020-07-28
Completion
2020-07-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04459520 on ClinicalTrials.gov